Bear Mountain At Reading Medicare and Medicaid Location: 1364 Main Street, Reading, Massachusetts 01867 Ratings: Phone: (781) 942-1210 |
News Archive
A UC researcher proposes that taste is in the tongue of the beholder when it comes to vodka.
University of Tennessee Extension will lead a new effort to combat the opioid crisis in rural Tennessee. PROMPT TN (Preventing Rural Opioid Misuse Through Partnerships and Training) will combine the expertise of multiple institutions to develop opioid-specific resources designed to increase understanding of underlying causes of opioid misuse with the goal of preventing addiction.
Scientists at The University of Western Ontario have discovered the biological link between stress, anxiety and depression. By identifying the connecting mechanism in the brain, this high impact research led by Stephen Ferguson of Robarts Research Institute shows exactly how stress and anxiety could lead to depression.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570 (the "'570 Patent"), 7,297,346 (the "'346 Patent") and RE37,516 (the "'516 Patent") for the Cephalon product NUVIGILĀ® (armodafinil) Tablets [C-IV].
› Verified 3 days ago